Efficacy and safety of selumetinib in patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: a systematic review and meta-analysis.
Han Y, Li B, Yu X, Liu J, Zhao W, Zhang D, Zhang J.
J Neurol. 2024 May;271(5):2379-2389. doi: 10.1007/s00415-024-12301-8. Epub 2024 Mar 19.
PMID:38502338
Control group design, contamination and drop-out in exercise oncology trials: a systematic review.
Steins Bisschop CN, Courneya KS, Velthuis MJ, Monninkhof EM, Jones LW, Friedenreich C, van der Wall E, Peeters PH, May AM.
PLoS One. 2015 Mar 27;10(3):e0120996. doi: 10.1371/journal.pone.0120996. eCollection 2015.